• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI SPRINT FIDELIS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI SPRINT FIDELIS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) Back to Search Results
Model Number 694958
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Pocket Stimulation (1463); Under-Sensing (1661)
Patient Problem Muscle Stimulation (1412)
Event Date 07/23/2018
Event Type  malfunction  
Manufacturer Narrative
Concomitant medical products: w1tr01 ipg, implanted: (b)(6) 2017; 407652 lead, implanted: (b)(6) 2018.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the patient experienced pocket stimulation caused by the right ventricular (rv) lead.It was noted that the right ventricular (rv) lead had high bipolar impedance measurements, high threshold measurements and over-sensing with noise.It was also noted that the rv lead had t-wave over-sensing (twos) and possible far field r-wave (ffrw) of the right atrial (ra) lead.The rv lead and ra lead remain in use.No further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
The initial reported event of the right ventricular (rv) lead had a polarity switch.Transmissions showed high rv bipolar impedance measurements, high rv threshold measurements, and over-sensing of the rv lead.The lead remains in use.No patient complications have been reported as a result of this event was submitted via an alternative summary report.As the summary report has been revoked, this new information is therefore being submitted via a 30-day report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received indicated the rv lead exhibited intermittent undersensing and additional oversensing noted although there is evidence of true arrhythmia at some points.The remote transmission also noted rv lead bipolar and unipolar impedance warnings noted as high undefined impedance and high sensing integrity counter (sic).The ra lead ffrw was observed and confirmed and a failed lead position checked was noted.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from following facility indicated the ra lead sensing and threshold was evaluated for failed position check and the lead was noted as functioning well.No action or intervention was taken on the ra lead and rv lead.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPRINT FIDELIS
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer (Section G)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key8931958
MDR Text Key156775547
Report Number2649622-2019-15235
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P920015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/26/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/12/2007
Device Model Number694958
Device Catalogue Number694958
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/28/2023
Date Device Manufactured04/18/2005
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-0070-2008
Patient Sequence Number1
Treatment
419388 LEAD
Patient Age65 YR
Patient SexFemale
Patient Weight79 KG
-
-